Changes in Immunophenotypes After Conversion from Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplant Recipients

被引：0
|
作者：
Yildiz, A. [1 ]
Cavusoglu, M. [1 ]
Adin, S. [2 ]
Caliskan, Y. [1 ]
Ozkok, A. [1 ]
Tasci, H. [3 ]
Deniz, G. [2 ]
Sariyar, M. [3 ]
机构：
[1] Istanbul Sch Med, Internal Med, Nephrol, Istanbul, Turkey
[2] Immunol Expt Med & Res Ctr, Istanbul, Turkey
[3] Medicana Organ Transplant Ctr, Gen Surg, Istanbul, Turkey
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2015年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1676
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Long-Term Renal Function in Liver Transplant Recipients After Conversion From Calcineurin Inhibitors to mTOR Inhibitors
    Huesing, Anna
    Schmidt, Martina
    Cicinnati, Vito R.
    Koch, Raphael
    Thoelking, Gerold
    Stella, Jaqueline
    Heinzow, Hauke
    Schmidt, Hartmut H.
    Kabar, Iyad
    [J]. ANNALS OF TRANSPLANTATION, 2015, 20
  • [2] THE SAFETY AND EFFICACY OF CONVERSION FROM CALCINEURIN INHIBITORS TO mTOR INHIBITORS IN STABLE KIDNEY TRANSPLANT RECIPIENTS
    Asanga, Abeyaratne
    Michael, Collins
    Kym, Bannister
    Graeme, Russ
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (08): : A1 - A1
  • [3] Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?
    Gonzalez-Vilchez, F.
    Vazquez de Prada, J. A.
    Paniagua, M. J.
    Gomez-Bueno, M.
    Arizon, J. M.
    Almenar, L.
    Roig, E.
    Delgado, J.
    Lambert, L.
    Perez-Villa, F.
    Sanz-Julve, M. L.
    Crespo-Leiro, M.
    Segovia, J.
    Lopez-Granados, A.
    Martinez-Dolz, L.
    Mirabet, S.
    Escribano, P.
    Diaz-Molina, B.
    Farrero, M.
    Blasco, T.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 171 (01) : 15 - 23
  • [4] Conversion from calcineurin inhibitors to mTOR inhibitors
    Bodziak, Kenneth A.
    Hrick, Donald E.
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2007, 12 (04) : 351 - 356
  • [5] Conversion from calcineurin inhibitors to mTOR inhibitors stabilizes diabetic and hypertensive nephropathy after liver transplant
    José M álamo
    Claudia Olivares
    Lydia Barrera
    Luis M Marín
    Gonzalo Suarez
    Carmen Bernal
    Juan Serrano
    Jordi Muntané
    Francisco J Padillo
    Miguel A Gómez
    [J]. World Journal of Transplantation, 2015, 5 (01) : 19 - 25
  • [6] PERIPHERAL LYMPHOCYTE CHANGES IN RENAL ALLOGRAFT RECIPIENTS AFTER CONVERSION TO MTOR INHIBITORS
    Llinas-Mallol, Laura
    Redondo, Dolores
    Jose Perez-Saez, Maria
    Raich-Regue, Dalia
    Mir, Marisa
    Yelamos, Jose
    Lopez-Botet, Miguel
    Pascual, Julio
    Crespo, Marta
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 618 - 618
  • [7] Calcineurin inhibitors in pediatric renal transplant recipients
    Filler G.
    [J]. Pediatric Drugs, 2007, 9 (3) : 165 - 174
  • [8] Conversion from Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplantation: A Single Centre Experience
    Oguz, Ebru Gok
    Yildirim, Tolga
    Merhametsiz, Ozgur
    Yayar, Ozlem
    Gursoy, Guner Karaveli
    Spulat, Ayhan Ha
    Ercan, Zafer
    Akoglu, Hadim
    Akdag, Seyit Ibrahim
    Ayli, Deniz
    [J]. TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2014, 23 (03): : 229 - 233
  • [9] Conversion to and from sirolimus in renal and hepatic transplant recipients treated with calcineurin inhibitors: Effect on renal function
    Moneim, HA
    Flechner, SM
    Goel, M
    Derweesh, IH
    Modlin, C
    Krishnamurthi, V
    Goldfarb, DA
    Novick, AC
    [J]. JOURNAL OF UROLOGY, 2005, 173 (04): : 419 - 419
  • [10] Elimination of calcineurin inhibitors in paediatric renal transplant recipients
    Prytula, A. A.
    Dorresteijn, E.
    van Rooij, R.
    Keijzer-Veen, M. G.
    Cransberg, K.
    [J]. PEDIATRIC NEPHROLOGY, 2011, 26 (09) : 1609 - 1609
12345